Development of injectable bioceramic drug delivery system for solid tumor treatment
1 online resource (56 pages) : PDF
University of North Carolina at Charlotte
According to the national cancer institute "In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States and 595,690 people will die from the disease" and "The number of people living beyond a cancer diagnosis reached nearly 14.5 million in 2014 and is expected to rise to almost 19 million by 2024." The usual treatment for cancer involves surgery, radiation, and chemotherapy. In an effort to reduce the side effects of chemotherapy while increasing its effectiveness, biomaterials are investigated as sustained drug delivery systems for targeted release. Recent studies have demonstrated the ability of custom made bioceramics to provide therapeutic doses of anticancer drug that eradicated tumor cells in vitro and in animal models. The objective of the research work in the present master’s thesis was to develop an injectable formula of bioceramic drug delivery system that can be injected directly into solid tumors. The drug release kinetics from the injectable ceramic was measured and its efficacy has been confirmed.
BIOCERAMICSBIOMATERIALSDRUG DELIVERYDRUG RELEASEINJECTABILITYSCPC
Dreau, DidierWei, Qiuming
Thesis (M.S.)--University of North Carolina at Charlotte, 2017.
This Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from the rights-holder(s). For additional information, see http://rightsstatements.org/page/InC/1.0/.
Copyright is held by the author unless otherwise indicated.